Immune Response to High-Dose vs. Standard Dose Influenza Vaccine

Elderly Immune System Clinical Trial

Official title: Immune Response to High-Dose vs. Standard Dose Influenza Vaccine

Status Active, not recruiting

Clinical Trial Summary

This 5-year proposal is a randomized study of split-virus influenza vaccine (SVV) in a high-dose (HD) vs. standard-dose (SD) formulation in each of five influenza seasons to define the key determinants of vaccine-mediated protection against influenza and how these immunologic mediators may be enhanced by vaccination with a newly approved high-dose influenza vaccine in older people

Clinical Trial Description

n/a

Related Conditions & MeSH terms

• Elderly Immune System
• Influenza, Human

• NCT number: NCT02297542
• Study type: Interventional
• Source: Health Sciences North Research Institute
• Status: Active, not recruiting
• Phase: Phase 4
• Start date: October 2014
• Completion date: December 2019